OrbiMed’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.4M Hold
5,779,071
0.78% 32
2025
Q1
$20.1M Hold
5,779,071
0.48% 45
2024
Q4
$59.5M Hold
5,779,071
1.22% 27
2024
Q3
$78.3M Hold
5,779,071
1.42% 21
2024
Q2
$75.1M Hold
5,779,071
1.48% 18
2024
Q1
$54.6M Hold
5,779,071
1% 33
2023
Q4
$63.4M Hold
5,779,071
1.27% 29
2023
Q3
$36.9M Hold
5,779,071
0.78% 48
2023
Q2
$27.8M Hold
5,779,071
0.5% 60
2023
Q1
$23.8M Hold
5,779,071
0.47% 61
2022
Q4
$24.9M Hold
5,779,071
0.48% 60
2022
Q3
$110K Buy
+5,779,071
New +$110K 2.04% 10